[ Price : $8.95]
FDA approves a Regeneron Pharmaceuticals BLA for Veopoz (pozelimab-bbfg) for treating adult and pediatric patients one year of age...[ Price : $8.95]
Merck says it will submit to FDA favorable data from its LITESPARK-005 Phase 3 trial evaluating Welireg (belzutifan) for treating ...[ Price : $8.95]
FDA updates its list of ultraviolet wand products that may present a potential risk of injury.[ Price : $8.95]
FDA clears a GE HealthCare 510(k) for its Portrait Mobile wireless and wearable monitoring device.[ Price : $8.95]
FDA approves Ipsens Sohonos as the first treatment for adults and some pediatric patients with fibrodysplasia ossificans progressi...[ Price : $8.95]
FDA says the Datascope/Maquet/Getinge recall of Cardiosave balloon pumps is Class 1.[ Price : $8.95]
FDA grants BlueWind Medical a de novo marketing authorization request for the Revi System, a tibial neuromodulation therapy for tr...[ Price : $8.95]
Federal Register notice: FDA announces a 9/18-19 public workshop entitled Optimizing the Use of Postapproval Pregnancy Safety Stud...